2020
Rate of Preventable Mortality in Hospitalized Patients: a Systematic Review and Meta-analysis
Rodwin BA, Bilan VP, Merchant NB, Steffens CG, Grimshaw AA, Bastian LA, Gunderson CG. Rate of Preventable Mortality in Hospitalized Patients: a Systematic Review and Meta-analysis. Journal Of General Internal Medicine 2020, 35: 2099-2106. PMID: 31965525, PMCID: PMC7351940, DOI: 10.1007/s11606-019-05592-5.Peer-Reviewed Original ResearchConceptsInpatient deathPreventable mortalityPreventable deathsMortality rateHospital mortality rateLife expectancyRandom-effects modelSystematic literature searchNumber of deathsWeb of ScienceHospital deathAdult patientsHospitalized patientsResultsSixteen studiesCase seriesPooled rateCochrane LibraryInclusion criteriaPatientsMeta-AnalysisSystematic reviewLiterature searchData extractionMortalityDeath
2011
Smoking Cessation Interventions for Patients with Depression: A Systematic Review and Meta-analysis
Gierisch JM, Bastian LA, Calhoun PS, McDuffie JR, Williams JW. Smoking Cessation Interventions for Patients with Depression: A Systematic Review and Meta-analysis. Journal Of General Internal Medicine 2011, 27: 351-360. PMID: 22038468, PMCID: PMC3286553, DOI: 10.1007/s11606-011-1915-2.Peer-Reviewed Original ResearchConceptsNicotine replacement therapySignificant depressive symptomsCessation interventionsCessation strategiesDepressive symptomsCurrent depressionBrief smoking cessation counselingBroad intervention categoriesSmoking cessation counselingPooled risk ratioSmoking cessation interventionStudy eligibility criteriaMantel-Haenszel methodMore smoking cessation interventionsRandom-effects modelDifferential effectsMood managementSynthesis MethodsTwoCessation counselingUnique RCTsAbstinence ratesCessation ratesCessation servicesReplacement therapyAntidepressant trials
2009
Ovarian Preservation by GnRH Agonists during Chemotherapy: A Meta-Analysis
Clowse ME, Behera MA, Anders CK, Copland S, Coffman CJ, Leppert PC, Bastian LA. Ovarian Preservation by GnRH Agonists during Chemotherapy: A Meta-Analysis. Journal Of Women's Health 2009, 18: 311-319. PMID: 19281314, PMCID: PMC2858300, DOI: 10.1089/jwh.2008.0857.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntineoplastic Agents, HormonalAntineoplastic Combined Chemotherapy ProtocolsConfidence IntervalsControlled Clinical Trials as TopicFemaleFertilityFertility Agents, FemaleGonadotropin-Releasing HormoneHumansNeoplasmsOdds RatioOvaryPregnancyPregnancy OutcomePrimary Ovarian InsufficiencyPrognosisYoung AdultConceptsFollicle-stimulating hormoneOvarian functionOvarian preservationGnRH agonistGnRHa therapyRelative riskGnRHa-treated womenOvarian function preservationSummary relative riskRandom-effects modelEnglish-language literaturePremenopausal womenCombination chemotherapyRandomized trialsFunction preservationAutoimmune diseasesOvarian failureHematologic malignanciesMenstrual cycleReproductive agePreservation optionsGnRHaChemotherapyMeeting abstractsSmall study
2006
Management of adnexal mass.
Myers ER, Bastian LA, Havrilesky LJ, Kulasingam SL, Terplan MS, Cline KE, Gray RN, McCrory DC. Management of adnexal mass. Evidence Report Technology Assessment 2006, 1-145. PMID: 17854238, PMCID: PMC4781260.Peer-Reviewed Original ResearchConceptsCA 125Adnexal massesNatural historyOvarian cancerFollowup strategiesDiagnostic strategiesOverall complication rateNationwide Inpatient SamplePercent of womenAlternative diagnostic strategiesBimanual pelvic examinationMalignant adnexal massesRandom-effects modelImportant clinical informationPremenopausal womenComplication rateAsymptomatic massRadiologic findingsAdverse outcomesFDG-PETUnilocular cystInpatient SamplePelvic examinationStudy populationDiagnostic modalities
2004
The Impact of Environmental Tobacco Smoke on Women's Risk of Dying from Heart Disease: A Meta-Analysis
Kaur S, Cohen A, Dolor R, Coffman CJ, Bastian LA. The Impact of Environmental Tobacco Smoke on Women's Risk of Dying from Heart Disease: A Meta-Analysis. Journal Of Women's Health 2004, 13: 888-897. PMID: 15671704, DOI: 10.1089/jwh.2004.13.888.Peer-Reviewed Original ResearchConceptsHeart diseaseCohort studyRelative riskCardiovascular diseaseEnvironmental tobacco smoke exposureRetrievable risk estimatesSummary relative riskNon-smoking womenTobacco smoke exposureHeart disease mortalityAmerican Heart AssociationEnvironmental tobacco smokeRandom-effects modelEnglish-language literatureETS exposurePassive smokeSmoke exposureHeart AssociationDisease mortalityTobacco smokeWoman's riskCounseling womenMeta-AnalysisDiseaseRisk estimates
1999
HORMONE REPLACEMENT THERAPY AND THE RISK OF COLORECTAL CANCER
Nanda K, Bastian L, Hasselblad V, Simel D. HORMONE REPLACEMENT THERAPY AND THE RISK OF COLORECTAL CANCER. Obstetrics And Gynecology 1999, 93: 880-888. DOI: 10.1097/00006250-199905001-00041.Peer-Reviewed Original ResearchHormone replacement therapyFatal colon cancerSummary relative riskRectal cancer incidenceHRT usersColon cancerColorectal cancerRelative riskReplacement therapyCancer incidenceAssociation of HRTUse of HRTRisk estimatesPostmenopausal HRT usersRecent HRT useRetrievable risk estimatesAdjusted risk estimatesMain outcome measuresConfidence intervalsDuration of useExposure of interestRandom-effects modelEnglish-language literatureTime of assessmentEstrogen usersHormone replacement therapy and the risk of colorectal cancer: a meta-analysis.
Nanda K, Bastian L, Hasselblad V, Simel D. Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Obstetrics And Gynecology 1999, 93: 880-8. PMID: 10912438, DOI: 10.1016/s0029-7844(98)00424-4.Peer-Reviewed Original ResearchConceptsHormone replacement therapyFatal colon cancerSummary relative riskRectal cancer incidenceHRT usersColon cancerColorectal cancerRelative riskReplacement therapyCancer incidenceAssociation of HRTUse of HRTRisk estimatesPostmenopausal HRT usersRecent HRT useRetrievable risk estimatesAdjusted risk estimatesMain outcome measuresConfidence intervalsDuration of useExposure of interestRandom-effects modelEnglish-language literatureTime of assessmentEstrogen users
1998
Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis
Nanda K, Bastian L, Hasselblad V, Simel D. Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Primary Care Update For OB/GYNS 1998, 5: 165. PMID: 10838309, DOI: 10.1016/s1068-607x(98)00064-x.Peer-Reviewed Original ResearchHormone replacement therapySummary relative riskRectal cancer incidenceHRT usersColon cancerReplacement therapyCancer incidenceRelative riskUse of HRTRisk estimatesPostmenopausal HRT usersRetrievable risk estimatesColorectal cancer incidenceAdjusted risk estimatesColon cancer mortalityRisk of deathMain outcome measuresConfidence intervalsDuration of useExposure of interestRandom-effects modelEnglish-language studiesTime of assessmentEstrogen usersHRT use